CSIMarket
 


Cytrx Corp  (CYTR)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cytrx's Quick Ratio

CYTR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




CYTR Quick Ratio (Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Current Liabilities Change -20.03 % -24.31 % -91.67 % -89.54 % -91.51 %
Y / Y Cash & cash equivalent Change -24.53 % -24.94 % -46.8 % -42.87 % -43.22 %
Quick Ratio MRQ 7.87 8.43 21.12 14.14 8.34
Overall Ranking # # # # #
Seq. Current Liabilities Change -6.62 % 139.27 % -35.29 % -44.69 % -11.62 %
Seq. Cash & cash equivalent Change -12.88 % -4.45 % -3.36 % -6.18 % -13.36 %



Quick Ratio forth quarter 2019 Comment
Despite sequential decrease in Current Liabilities, Quick Ratio detoriated to 7.87 below company average Quick Ratio.

Within Biotechnology & Drugs industry 46 other companies have achieved higher Quick Ratio than Cytrx in forth quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are CYTR Segments?
See Quick Ratio CYTR on the trailing twelve month basis
Quick Ratio forth quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 47
Healthcare Sector # 143
Overall Market # 314


Quick Ratio Statistics
High Average Low
21.12 4.5 1.01
(Jun 30 2019)   (Jun 30 2012)




Financial Statements
Cytrx's Current Liabilities $ 2 Millions Visit CYTR's Balance sheet
Cytrx's Cash & cash equivalent $ 16 Millions Visit CYTR's Balance sheet
Source of CYTR's Sales Visit CYTR's Sales by Geography




Companies with similar Quick Ratio in the quarter endingDec 31 2019, within Biotechnology & Drugs Industry Quick RatioDec 31 2019 MRQ Cash & cash equivalentDec 31 2019 MRQ Current Liabilities
Homology Medicines Inc   21.20 $ 262.388  Millions$ 12.374  Millions
Aptose Biosciences Inc   19.45 $ 97.600  Millions$ 5.018  Millions
Eidos Therapeutics, Inc.  18.33 $ 191.157  Millions$ 10.430  Millions
Lixte Biotechnology Holdings Inc   18.10 $ 2.599  Millions$ 0.144  Millions
Madrigal Pharmaceuticals inc   17.69 $ 439.045  Millions$ 24.815  Millions
89bio Inc   16.64 $ 93.335  Millions$ 5.609  Millions
Crispr Therapeutics Ag  16.53 $ 943.771  Millions$ 57.106  Millions
Scpharmaceuticals Inc   15.04 $ 72.624  Millions$ 4.830  Millions
Protokinetix, Inc.  14.79 $ 0.377  Millions$ 0.026  Millions
G1 Therapeutics Inc   13.62 $ 269.208  Millions$ 19.769  Millions
Satsuma Pharmaceuticals Inc   13.51 $ 107.697  Millions$ 7.971  Millions
Oxford Immunotec Global Plc  13.12 $ 181.270  Millions$ 13.819  Millions
Acceleron Pharma inc   12.93 $ 431.369  Millions$ 33.373  Millions
Organovo Holdings, Inc.  12.92 $ 30.467  Millions$ 2.358  Millions
Enzon Pharmaceuticals, Inc.  12.87 $ 5.446  Millions$ 0.423  Millions
Repligen Corp  11.81 $ 528.392  Millions$ 44.756  Millions
Jounce Therapeutics, Inc.  11.73 $ 168.843  Millions$ 14.400  Millions
Galera Therapeutics Inc   11.58 $ 112.290  Millions$ 9.694  Millions
Aerpio Pharmaceuticals Inc   11.56 $ 38.525  Millions$ 3.334  Millions
Capricor Therapeutics Inc   11.29 $ 9.885  Millions$ 0.876  Millions
Assembly Biosciences Inc   11.21 $ 274.043  Millions$ 24.440  Millions
Artara Therapeutics Inc   10.60 $ 6.181  Millions$ 0.583  Millions
Enochian Biosciences Inc  10.41 $ 8.627  Millions$ 0.829  Millions
Voyager Therapeutics Inc   9.78 $ 281.533  Millions$ 28.779  Millions
Iovance Biotherapeutics Inc   9.65 $ 307.081  Millions$ 31.832  Millions
Livongo Health Inc   9.35 $ 391.738  Millions$ 41.875  Millions
Denali Therapeutics Inc   9.16 $ 415.356  Millions$ 45.344  Millions
Arca Biopharma, Inc.  9.03 $ 8.363  Millions$ 0.926  Millions
Immunomedics Inc   9.02 $ 613.178  Millions$ 67.966  Millions
Regenxbio Inc   8.80 $ 296.210  Millions$ 33.676  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LIXT's Profile

Stock Price

LIXT's Financials

Business Description

Fundamentals

Charts & Quotes

LIXT's News

Suppliers

LIXT's Competitors

Customers & Markets

Economic Indicators

LIXT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071